John L. Armstrong
Keine laufenden Positionen mehr
Profil
John L.
Armstrong formerly worked at Genaera Corp., as President & Chief Executive Officer from 2005 to 2009, Mentor Biopharmaceuticals, Inc., as Chief Executive Officer from 1999 to 2001, UroCor, Inc., as Senior Vice President-Business Development from 1999 to 2001, Endo Health Solutions, Inc., as President, CorMedix, Inc., as EVP-Technical Operations & Head-Human Resources from 2014 to 2021, Marion Merrell Dow, Inc., as Vice President-Operation, Oread, Inc., as President & Chief Operating Officer from 1998 to 1999, DuPont Merck Pharmaceutical Co., as President-Worldwide Manufacturing from 1991 to 1998, and Correvio LLC, as President-Operations from 2010 to 2013.
Mr. Armstrong received his undergraduate degree from Juniata College and Masters Business Admin degree in 1993 from Century College.
Ehemalige bekannte Positionen von John L. Armstrong
| Unternehmen | Position | Ende |
|---|---|---|
| CORMEDIX INC. | Chief Tech/Sci/R&D Officer | 04.10.2021 |
Correvio LLC
 Correvio LLC Medical DistributorsDistribution Services Part of Advanz Pharma Corp. Ltd., Correvio LLC is a wholesaler of pharmaceuticals. The private company is based in Chester, PA. | President | 01.01.2013 |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Chief Executive Officer | 08.07.2009 |
Mentor Biopharmaceuticals, Inc.
 Mentor Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Mentor Biopharmaceuticals, Inc. is a private company that manufactures products for the treatment of prostate cancer. The company is based in Oklahoma City, OK. Mentor Biopharmaceuticals was acquired by Core Oncology, Inc. from Coloplast A/S on June 12, 2007. | President | 01.11.2001 |
UroCor, Inc.
 UroCor, Inc. Hospital/Nursing ManagementHealth Services UroCor, Inc. provides diagnostic and therapeutic services for urological disorders. It helps in detecting, diagnosing, treating & managing- prostate cancer, bladder cancer, kidney stones, and other complex urologic disorders. The company is located in Oklahoma City, OK | Corporate Officer/Principal | 01.11.2001 |
Ausbildung von John L. Armstrong
| Juniata College | Undergraduate Degree |
| Century College | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CORMEDIX INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
UroCor, Inc.
UroCor, Inc. Hospital/Nursing ManagementHealth Services UroCor, Inc. provides diagnostic and therapeutic services for urological disorders. It helps in detecting, diagnosing, treating & managing- prostate cancer, bladder cancer, kidney stones, and other complex urologic disorders. The company is located in Oklahoma City, OK | Health Services |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
Oread, Inc.
 Oread, Inc. Pharmaceuticals: MajorHealth Technology Oread, Inc. operates in drug development and manufacturing operations. The private company is based in Lawrence, KS and has subsidiaries in the United States. | Health Technology |
Mentor Biopharmaceuticals, Inc.
Mentor Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Mentor Biopharmaceuticals, Inc. is a private company that manufactures products for the treatment of prostate cancer. The company is based in Oklahoma City, OK. Mentor Biopharmaceuticals was acquired by Core Oncology, Inc. from Coloplast A/S on June 12, 2007. | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Correvio LLC
Correvio LLC Medical DistributorsDistribution Services Part of Advanz Pharma Corp. Ltd., Correvio LLC is a wholesaler of pharmaceuticals. The private company is based in Chester, PA. | Distribution Services |
